Cargando…
A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A
Background: As a Class A bioterrorism agent, botulinum neurotoxin serotype A (BoNT/A) carries the risk of being used by terrorists to cause mass poisoning. The microneedle (MN) patch has a great potential for application as a novel vaccine delivery method. The aim of this study is to develop a therm...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781108/ https://www.ncbi.nlm.nih.gov/pubmed/36548778 http://dx.doi.org/10.3390/toxins14120881 |
_version_ | 1784856993042792448 |
---|---|
author | Zhao, Baohua Jin, Zhiying Yu, Yunzhou Li, Yue Wang, Jing Wan, Wei Hu, Chenyi Li, Xiaoyang Li, Yanwei Xin, Wenwen Kang, Lin Yang, Hao Wang, Jinglin Gao, Shan |
author_facet | Zhao, Baohua Jin, Zhiying Yu, Yunzhou Li, Yue Wang, Jing Wan, Wei Hu, Chenyi Li, Xiaoyang Li, Yanwei Xin, Wenwen Kang, Lin Yang, Hao Wang, Jinglin Gao, Shan |
author_sort | Zhao, Baohua |
collection | PubMed |
description | Background: As a Class A bioterrorism agent, botulinum neurotoxin serotype A (BoNT/A) carries the risk of being used by terrorists to cause mass poisoning. The microneedle (MN) patch has a great potential for application as a novel vaccine delivery method. The aim of this study is to develop a thermally stable, dissolving microneedle patch for the delivery of a recombinant protein vaccine using a recombinant C-terminal heavy chain of BoNT/A (Hc of BoNT/A, AHc) to prevent botulism. Methods: Fish gelatin, a natural non-toxic and bacteriostatic material, was selected as the microneedle matrix for the preparation of the dissolving microneedle vaccine. Subsequently, the mechanical performance, bacteriostatic properties, vaccination effect, and stability of the microneedle patches were evaluated using instruments such as the displacement-force test station and optical coherence tomography (OCT) scanner. Results: Fish gelatin matrix at high concentrations has good bacteriostatic properties, and excellent mechanical performance and vaccination effect, meeting the necessities of a vaccine. In both in vivo and in vitro neutralization experiments, MN vaccines containing different antigen doses achieved the same protective efficacy as subcutaneous vaccinations, protecting mice against 10(6) LD(50) of BoNT/A injected intraperitoneally. Thermal stability analysis of the MN vaccines revealed that the fish gelatin matrix protected the AHc vaccine from protein denaturation even after 7 days of storage at 37 °C and enabled the vaccine patches to maintain good immunogenicity and protective efficacy even after 6 months of storage at room temperature. Conclusion: In this study, we successfully prepared a bacteriostatic MN patch using a fish gelatin matrix that not only has a good vaccination effect, but also obviates the need for a cold chain for the AHc vaccine, providing the possibility of rapid, painless, and large-scale vaccination. |
format | Online Article Text |
id | pubmed-9781108 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97811082022-12-24 A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A Zhao, Baohua Jin, Zhiying Yu, Yunzhou Li, Yue Wang, Jing Wan, Wei Hu, Chenyi Li, Xiaoyang Li, Yanwei Xin, Wenwen Kang, Lin Yang, Hao Wang, Jinglin Gao, Shan Toxins (Basel) Article Background: As a Class A bioterrorism agent, botulinum neurotoxin serotype A (BoNT/A) carries the risk of being used by terrorists to cause mass poisoning. The microneedle (MN) patch has a great potential for application as a novel vaccine delivery method. The aim of this study is to develop a thermally stable, dissolving microneedle patch for the delivery of a recombinant protein vaccine using a recombinant C-terminal heavy chain of BoNT/A (Hc of BoNT/A, AHc) to prevent botulism. Methods: Fish gelatin, a natural non-toxic and bacteriostatic material, was selected as the microneedle matrix for the preparation of the dissolving microneedle vaccine. Subsequently, the mechanical performance, bacteriostatic properties, vaccination effect, and stability of the microneedle patches were evaluated using instruments such as the displacement-force test station and optical coherence tomography (OCT) scanner. Results: Fish gelatin matrix at high concentrations has good bacteriostatic properties, and excellent mechanical performance and vaccination effect, meeting the necessities of a vaccine. In both in vivo and in vitro neutralization experiments, MN vaccines containing different antigen doses achieved the same protective efficacy as subcutaneous vaccinations, protecting mice against 10(6) LD(50) of BoNT/A injected intraperitoneally. Thermal stability analysis of the MN vaccines revealed that the fish gelatin matrix protected the AHc vaccine from protein denaturation even after 7 days of storage at 37 °C and enabled the vaccine patches to maintain good immunogenicity and protective efficacy even after 6 months of storage at room temperature. Conclusion: In this study, we successfully prepared a bacteriostatic MN patch using a fish gelatin matrix that not only has a good vaccination effect, but also obviates the need for a cold chain for the AHc vaccine, providing the possibility of rapid, painless, and large-scale vaccination. MDPI 2022-12-16 /pmc/articles/PMC9781108/ /pubmed/36548778 http://dx.doi.org/10.3390/toxins14120881 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Zhao, Baohua Jin, Zhiying Yu, Yunzhou Li, Yue Wang, Jing Wan, Wei Hu, Chenyi Li, Xiaoyang Li, Yanwei Xin, Wenwen Kang, Lin Yang, Hao Wang, Jinglin Gao, Shan A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A |
title | A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A |
title_full | A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A |
title_fullStr | A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A |
title_full_unstemmed | A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A |
title_short | A Thermostable Dissolving Microneedle Vaccine with Recombinant Protein of Botulinum Neurotoxin Serotype A |
title_sort | thermostable dissolving microneedle vaccine with recombinant protein of botulinum neurotoxin serotype a |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781108/ https://www.ncbi.nlm.nih.gov/pubmed/36548778 http://dx.doi.org/10.3390/toxins14120881 |
work_keys_str_mv | AT zhaobaohua athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT jinzhiying athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT yuyunzhou athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT liyue athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT wangjing athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT wanwei athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT huchenyi athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT lixiaoyang athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT liyanwei athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT xinwenwen athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT kanglin athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT yanghao athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT wangjinglin athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT gaoshan athermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT zhaobaohua thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT jinzhiying thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT yuyunzhou thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT liyue thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT wangjing thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT wanwei thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT huchenyi thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT lixiaoyang thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT liyanwei thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT xinwenwen thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT kanglin thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT yanghao thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT wangjinglin thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea AT gaoshan thermostabledissolvingmicroneedlevaccinewithrecombinantproteinofbotulinumneurotoxinserotypea |